X
19
Boehringer Ingelheim GmbH, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LINAGLIPTIN, with a corresponding application number 201280.
Regulatory Information RX
With a dosage strength 5MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2011-05-02
Therapeutic Equivalence (TE) Code AB